CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 target
Drug / intervention
Office Based Vergence and Accommodative Therapybehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03593031
NCT03593031N/ACompleted

Functional Neural Mechanism of Vision Therapy for Patients With Convergence Insufficiency

New Jersey Institute of Technology·interventional·Posted Jul 19, 2018·Updated Feb 25, 2020

In Brief

A clinical study evaluating Office Based Vergence and Accommodative Therapy for Convergence Insufficiency. Completed, enrolled 100 participants across 1 site.

Detailed Summary

Convergence insufficiency (CI) is a prevalent binocular vision disorder with symptoms that include double/blurred vision, eyestrain, and headaches when engaged in reading or other near work. CI is present in 4% of the population where approximately 27% of CI patients do not improve even with validated therapy. The project will quantitatively study changes in convergence eye movements and neural substrates before and after validated therapy in CI patients. This knowledge can lead to improvements in currently validated therapy, reduction in therapy sessions, and reduced healthcare costs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 19, 2018
Enrollment StartApr 1, 2014
Primary CompletionApr 1, 2019
Study CompletionJan 1, 2020
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 8.0 years ago

Interventions

Office Based Vergence and Accommodative Therapybehavioral

Exercises that will stimulate disparity vergence or accommodation independently and then combined will be used.